Registration projects in health and health care
Currently the reimbursement of personalized medicines is not coupled with that of the accompanying biomarker which often leads to a delay in reimbursement of the predictive tests as compared to the personalized medicine. To better align reimbursement of the medicine and the predictive test, a coupled reimbursement procedure, will be created that will allow a monthly update of reimbursed personalized medicines and their corresponding predictive test, and as such will be flexible enough to adjust for the rapid evolving field...
De farmanet DB FARM omvat alle uitgaven aangaande ambulante geneesmiddelen van alle verzekerden in België. Deze data worden projectmatig ter beschikking gesteld aan IMA analisten voor studies die IMA uitvoert in opdracht van de VI en mits positief advies van de privacy commissie SC gezondheidszorgen kunnen verschillende instellingen in functie van hun wettelijke opdrachten toegang krijgen.
Molecular detection is currently a part of clinical oncology diagnostics. The recent grow of advanced molecular technologies enables for a certain number of cases to optimize the treatment by incorporating individual, molecular DNA-characteristics of the tumor and of the patient himself: the so-called ‘Targeted Next-Generation-Sequencing (NGS).
The introduction of NGS in molecular oncology diagnostics requires a profound preparatory phase, both in the field and on policy level. A feasibility study, performed by the Cancer center (WIV-ISP) and the KCE, resulted in a roadbook ‘...